Commentary | Published:

The perils of federalizing vaccine production

Nature Biotechnology volume 20, page 113 (2002) | Download Citation

Subjects

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Author information

Affiliations

  1. Sam Kazman (kazman@cei.org) is general counsel at the Competitive Enterprise Institute.

    • Sam Kazman
  2. Henry I. Miller (miller@hoover.stanford.edu) is a physician, molecular biologist, and fellow at the Hoover Institution.

    • Henry I. Miller

Authors

  1. Search for Sam Kazman in:

  2. Search for Henry I. Miller in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt0202-113

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing